YHB Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$689K Sell
5,454
-350
-6% -$46.1K 0.04% 198
2026
Q1
$809K Sell
5,804
-100
-2% -$14K 0.06% 181
2025
Q4
$725K Hold
5,904
0.05% 187
2025
Q3
$655K Hold
5,904
0.05% 194
2025
Q2
$655K Sell
5,904
-100
-2% -$10.6K 0.05% 194
2025
Q1
$673K Hold
6,004
0.06% 182
2024
Q4
$555K Sell
6,004
-26
-0.4% -$2.34K 0.05% 191
2024
Q3
$506K Sell
6,030
-300
-5% -$22.9K 0.04% 198
2024
Q2
$434K Sell
6,330
-186
-3% -$12.4K 0.04% 207
2024
Q1
$477K Sell
6,516
-475
-7% -$36.5K 0.04% 195
2023
Q4
$566K Sell
6,991
-1,350
-16% -$105K 0.05% 179
2023
Q3
$625K Sell
8,341
-140
-2% -$10.8K 0.06% 171
2023
Q2
$654K Hold
8,481
0.06% 168
2023
Q1
$704K Sell
8,481
-80
-0.9% -$6.63K 0.07% 164
2022
Q4
$735K Sell
8,561
-1,620
-16% -$128K 0.08% 160
2022
Q3
$628K Sell
10,181
-179
-2% -$11.3K 0.07% 170
2022
Q2
$640K Sell
10,360
-299
-3% -$18.5K 0.07% 171
2022
Q1
$634K Sell
10,659
-151
-1% -$9.65K 0.06% 182
2021
Q4
$785K Sell
10,810
-484
-4% -$33.3K 0.06% 179
2021
Q3
$789K Sell
11,294
-783
-6% -$55K 0.07% 176
2021
Q2
$832K Sell
12,077
-335
-3% -$22.4K 0.07% 178
2021
Q1
$830K Sell
12,412
-1,575
-11% -$102K 0.07% 176
2020
Q4
$815K Sell
13,987
-833
-6% -$50.3K 0.08% 172
2020
Q3
$937K Sell
14,820
-6,365
-30% -$441K 0.1% 158
2020
Q2
$1.63M Sell
21,185
-65
-0.3% -$4.98K 0.24% 85
2020
Q1
$1.59M Buy
21,250
+634
+3% +$43.8K 0.27% 83
2019
Q4
$1.34M Sell
20,616
-8,120
-28% -$529K 0.19% 97
2019
Q3
$1.82M Buy
28,736
+6,960
+32% +$455K 0.28% 87
2019
Q2
$1.47M Sell
21,776
-169
-0.8% -$11.1K 0.23% 97
2019
Q1
$1.43M Sell
21,945
-4,474
-17% -$297K 0.22% 100
2018
Q4
$1.65M Buy
26,419
+1,175
+5% +$82.1K 0.3% 87
2018
Q3
$1.95M Sell
25,244
-847
-3% -$64K 0.29% 86
2018
Q2
$1.85M Sell
26,091
-507
-2% -$35.8K 0.3% 93
2018
Q1
$2M Sell
26,598
-371
-1% -$29.5K 0.34% 88
2017
Q4
$1.93M Sell
26,969
-1,041
-4% -$79.1K 0.33% 85
2017
Q3
$2.27M Sell
28,010
-9,058
-24% -$693K 0.41% 78
2017
Q2
$2.62M Buy
37,068
+6,609
+22% +$440K 0.45% 66
2017
Q1
$2.09M Sell
30,459
-10,105
-25% -$711K 0.4% 73
2016
Q4
$2.9M Sell
40,564
-6,563
-14% -$488K 0.61% 57
2016
Q3
$3.73M Buy
47,127
+765
+2% +$62.1K 0.9% 34
2016
Q2
$3.87M Sell
46,362
-2,405
-5% -$213K 0.85% 39
2016
Q1
$4.48M Sell
48,767
-347
-0.7% -$31.3K 1.21% 29
2015
Q4
$4.97M Buy
49,114
+6,666
+16% +$694K 1.13% 30
2015
Q3
$4.17M Buy
42,448
+1,510
+4% +$168K 0.98% 31
2015
Q2
$4.79M Buy
40,938
+887
+2% +$96.9K 1.05% 28
2015
Q1
$3.93M Buy
40,051
+511
+1% +$51.9K 0.88% 37
2014
Q4
$3.73M Buy
39,540
+2,482
+7% +$257K 0.85% 36
2014
Q3
$3.94M Buy
37,058
+280
+0.8% +$27.4K 0.95% 38
2014
Q2
$3.05M Buy
36,778
+2,097
+6% +$163K 0.74% 53
2014
Q1
$2.46M Buy
34,681
+4,387
+14% +$344K 0.62% 61
2013
Q4
$2.27M Buy
30,294
+2,365
+8% +$165K 0.61% 56
2013
Q3
$1.76M Buy
27,929
+2,085
+8% +$125K 0.52% 66
2013
Q2
$1.32M Buy
+25,844
New +$1.35M 0.41% 79

Other funds holding GILD

YHB Investment Advisors's GILD Position: Q2 2026 in Review

YHB Investment Advisors reduced its Gilead Sciences (GILD) stake by 6% in Q2 2026, selling an estimated $46.1K and leaving 5,454 shares worth $689K. The position accounts for 0.04% of the portfolio, ranked #198.

YHB Investment Advisors first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.97M in Q4 2015. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • YHB Investment Advisors held 5,454 shares of Gilead Sciences worth $689K as of Q2 2026.
  • YHB Investment Advisors sold 350 Gilead Sciences shares in Q2 2026, an estimated $46.1K.
  • Gilead Sciences made up 0.04% of YHB Investment Advisors's portfolio in Q2 2026, its #198 holding.
  • YHB Investment Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • YHB Investment Advisors's Gilead Sciences position peaked at $4.97M in Q4 2015.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on YHB Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.